CPT Camden Property Trust (CPT) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0000906345
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about CPT
Insiders, 180 days
-$3.4M net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-04-01
Camden Property Trust insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CAMDEN PROPERTY TRUST insiders sold a net $3.4M of stock across 62 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Jan 6, 2026.
- The trade is 10.1% of the 297,437 shares held after it.
- No other insider sold within 30 days.
Insider activity: Executive Chairman CAMPO RICHARD J sold about $3.4M of CPT on Jun 5, 2026, the largest insider sale at the company since 2025.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Mar 10, 2025.
- The trade is 0.4% of the 39,640 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Chief Accounting Officer Gallagher Michael P sold about $18.3K of CPT on Feb 18, 2026; 1 other insider sold within 30 days.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jan 6, 2026.
- The trade is 0.0% of the 94,468 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: EVP - Chief Operating Officer Baker Laurie sold about $542 of CPT on Feb 18, 2026; 1 other insider sold within 30 days.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jan 6, 2026.
- The trade is 2.3% of the 94,473 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: EVP - Chief Operating Officer Baker Laurie sold about $234.5K of CPT on Feb 18, 2026; 1 other insider sold within 30 days.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jan 5, 2026.
- The trade is 0.2% of the 96,636 shares held after it.
- 6 other insiders sold within 30 days.
Insider activity: EVP - Chief Operating Officer Baker Laurie sold about $16.5K of CPT on Jan 6, 2026; 6 other insiders sold within 30 days.62 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$3.4M over 180 days
below 85% of Real Estate
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+81.7% year over year
more than 95% of Real Estate
Margin
2964.9% net margin
more than 98% of Real Estate
Buybacks
$433.0M repurchased, FY to 2026-06-30
more than 96% of Real Estate
Short interest
5.2% of the float short (float per yahoo 2026-10-26) · 3.8 days to cover · settled 2026-09-30
more than 59% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CPT
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+0.1%12M
Insider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CPT: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CPT
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-04-01 · disclosed 43 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CPT planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Richard J. Campo
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.3M
$8.3M
n/a
+30%
+38%
2024
$7.2M
$7.2M
$4.7M
+32%
+34%
2023
$6.9M
$6.9M
$4.2M
+9%
+23%
2022
$6.2M
$6.2M
$3.7M
+18%
+8%
2021
$4.3M
$4.3M
$3.7M
+83%
+43%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $3.4M sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
CPT financials
Revenue growth
+81.7%
XBRL, annual
Net margin
2964.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$13.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CPT
| FY Dec 2025 | $13.0M |
| FY Dec 2024 | $7.1M |
| FY Dec 2023 | $3.5M |
| FY Dec 2022 | $5.2M |
| FY Dec 2021 | $10.5M |
| Jun 2026 | $3.1M |
| Mar 2026 | $2.1M |
| Dec 2025 | $5.3M |
| Sep 2025 | $2.6M |
| Jun 2025 | $2.6M |
| Mar 2025 | $2.5M |
| Dec 2024 | $1.5M |
| Sep 2024 | $1.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+2,486%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CPT
| FY Dec 2025 | +2,965% |
| FY Dec 2024 | +2,288% |
| FY Dec 2023 | +11,687% |
| FY Dec 2022 | +12,599% |
| FY Dec 2021 | +2,886% |
| Jun 2026 | +600.1% |
| Mar 2026 | +1,981% |
| Dec 2025 | +2,954% |
| Sep 2025 | +4,247% |
| Jun 2025 | +3,064% |
| Mar 2025 | +1,561% |
| Dec 2024 | +2,642% |
| Sep 2024 | -246.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CPT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | $573.4M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | $195.8M |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | $152.4M |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
1.28x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity CPT
| FY Dec 2025 | 0.89x |
| FY Dec 2024 | 0.75x |
| FY Dec 2023 | 0.75x |
| FY Dec 2022 | 0.74x |
| FY Dec 2021 | 0.76x |
| Jun 2026 | 1.28x |
| Mar 2026 | 1.06x |
| Dec 2025 | 0.89x |
| Sep 2025 | 0.82x |
| Jun 2025 | 0.83x |
| Mar 2025 | 0.81x |
| Dec 2024 | 0.75x |
| Sep 2024 | 0.73x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.17x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt CPT
| FY Dec 2025 | 0.21x |
| FY Dec 2024 | 0.22x |
| FY Dec 2023 | 0.21x |
| FY Dec 2022 | 0.20x |
| FY Dec 2021 | 0.18x |
| Jun 2026 | 0.17x |
| Mar 2026 | 0.19x |
| Dec 2025 | 0.21x |
| Sep 2025 | 0.21x |
| Jun 2025 | 0.21x |
| Mar 2025 | 0.21x |
| Dec 2024 | 0.22x |
| Sep 2024 | 0.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CPT
| FY Dec 2025 | +8.5% |
| FY Dec 2024 | +3.4% |
| FY Dec 2023 | +8.1% |
| FY Dec 2022 | +14.2% |
| FY Dec 2021 | +8.0% |
| Jun 2026 | +7.8% |
| Mar 2026 | +9.0% |
| Dec 2025 | +8.5% |
| Sep 2025 | +5.8% |
| Jun 2025 | +3.3% |
| Mar 2025 | +2.5% |
| Dec 2024 | +3.4% |
| Sep 2024 | +7.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CPT
| FY Dec 2025 | +4.3% |
| FY Dec 2024 | +1.8% |
| FY Dec 2023 | +4.3% |
| FY Dec 2022 | +7.6% |
| FY Dec 2021 | +4.0% |
| Jun 2026 | +3.5% |
| Mar 2026 | +4.3% |
| Dec 2025 | +4.3% |
| Sep 2025 | +3.0% |
| Jun 2025 | +1.7% |
| Mar 2025 | +1.3% |
| Dec 2024 | +1.8% |
| Sep 2024 | +3.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CPT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CPT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
33.77x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CPT
| FY Dec 2025 | 31.10x |
| FY Dec 2024 | 77.36x |
| FY Dec 2023 | 26.76x |
| FY Dec 2022 | 18.68x |
| FY Dec 2021 | 60.36x |
| Jun 2026 | 37.91x |
| Mar 2026 | 27.28x |
| Dec 2025 | 31.10x |
| Sep 2025 | 43.23x |
| Jun 2025 | 78.80x |
| Mar 2025 | 112.20x |
| Dec 2024 | 77.36x |
| Sep 2024 | 38.97x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$15.1B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value CPT
| FY Dec 2025 | $15.6B |
| FY Dec 2024 | $15.8B |
| FY Dec 2023 | $14.1B |
| FY Dec 2022 | $15.6B |
| FY Dec 2021 | $20.8B |
| Jun 2026 | $16.3B |
| Mar 2026 | $14.3B |
| Dec 2025 | $15.6B |
| Sep 2025 | $15.1B |
| Jun 2025 | $15.8B |
| Mar 2025 | $16.8B |
| Dec 2024 | $15.8B |
| Sep 2024 | $16.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield CPT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | +3.1% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.30x
P/E over trailing EPS growth of 111%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CPT
| FY Dec 2025 | 0.23x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.18x |
| FY Dec 2021 | 0.44x |
| Jun 2026 | 0.34x |
| Mar 2026 | 0.12x |
| Dec 2025 | 0.23x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 0.75x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $13.0M | $7.1M | $3.5M | $5.2M |
| Net income | $384.5M | $163.3M | $403.3M | $653.6M |
| EPS (diluted) | 3.54 | 1.50 | 3.70 | 6.04 |
| Operating cash flow | $826.6M | $774.9M | $795.0M | $744.7M |
| Cash | $25.2M | $21.0M | $259.7M | $10.7M |
| Long-term debt | $3.9B | $3.5B | $3.7B | $3.7B |
| Buybacks | $270.7M | $50.0M | $0 | $0 |
| Dividends paid | $460.9M | $451.0M | $434.9M | $396.8M |
SEC XBRL, fiscal years, as known on 2026-10-28
CPT Stock Sonar score 5/7 axes
Find similar shapesCompareCPT ranks highest on growth (95th percentile) and profitability (72nd), and lowest on insider conviction (7th), among Real Estate peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CPT filings, in plain words
Are Camden Property Trust insiders buying or selling CPT?
In the 180 days to 2026-10-28, Camden Property Trust insiders were net sellers, a net $3.4M across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded CPT?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Julie Johnson dated 2025-04-01.
Read the full summary
In the 180 days to 2026-10-28, Camden Property Trust insiders were net sellers of CPT, a net $3.4M across purchases and sales reported on Form 4 by 1 seller. Members of Congress have disclosed trades in CPT, none in the last year; the latest on record is a sale by Julie Johnson dated 2025-04-01. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
